BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat

NEXT STORY
ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors
PREV STORY
Hua Medicine Announces 2019 Annual Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna

PORTLAND, Ore. and CAMBRIDGE, Mass., Dec. 22, 2017 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a ...

author_avatar
NASDAQ Market News

Clinical Genomics to Present Data at ASCO Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

BRIDGEWATER, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing ...

author_avatar
NASDAQ Market News